Pinkerton Retirement Specialists’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.76M Sell
34,253
-35,028
-51% -$6.59M 0.58% 22
2026
Q1
$6.37M Buy
69,281
+34,264
+98% +$6.61M 0.58% 31
2025
Q4
$6.44M Sell
35,017
-384
-1% -$67.3K 0.66% 32
2025
Q3
$5.43M Buy
35,401
+2,478
+8% +$375K 0.58% 40
2025
Q2
$4.6M Buy
32,923
+940
+3% +$132K 0.55% 43
2025
Q1
$4.7M Buy
31,983
+268
+0.8% +$38.8K 0.61% 39
2024
Q4
$4.16M Sell
31,715
-653
-2% -$91.4K 0.6% 50
2024
Q3
$5.04M Buy
32,368
+3,260
+11% +$526K 0.73% 35
2024
Q2
$4.54M Buy
29,108
+1,314
+5% +$198K 0.7% 34
2024
Q1
$3.77M Buy
27,794
+8,011
+40% +$1.06M 0.61% 46
2023
Q4
$2.66M Sell
19,783
-963
-5% -$125K 0.51% 45
2023
Q3
$2.81M Sell
20,746
-11
-0.1% -$1.5K 0.61% 36
2023
Q2
$2.97M Buy
20,757
+228
+1% +$33.5K 0.59% 38
2023
Q1
$2.85M Buy
20,529
+385
+2% +$51.8K 0.53% 42
2022
Q4
$2.73M Buy
20,144
+1,613
+9% +$202K 0.59% 32
2022
Q3
$2.03M Sell
18,531
-1,261
-6% -$160K 0.78% 43
2022
Q2
$2.62M Sell
19,792
-2,988
-13% -$392K 0.79% 32
2022
Q1
$3.02M Buy
22,780
+2,274
+11% +$273K 0.67% 43
2021
Q4
$2.39M Buy
20,506
+848
+4% +$99.8K 0.42% 59
2021
Q3
$2.36M Buy
19,658
+747
+4% +$87K 0.46% 62
2021
Q2
$2.27M Buy
18,911
+560
+3% +$61.4K 0.44% 63
2021
Q1
$1.82M Buy
18,351
+1,298
+8% +$130K 0.38% 75
2020
Q4
$1.71M Sell
17,053
-715
-4% -$75.7K 0.41% 73
2020
Q3
$1.95M Sell
17,768
-1,047
-6% -$116K 0.53% 50
2020
Q2
$1.99M Buy
18,815
+5,171
+38% +$534K 0.63% 40
2020
Q1
$1.22M Sell
13,644
-25,931
-66% -$2.44M 0.85% 21
2019
Q4
$3.95M Buy
39,575
+642
+2% +$60.4K 1.26% 18
2019
Q3
$3.47M Buy
38,933
+1,129
+3% +$97.9K 1.19% 18
2019
Q2
$3.12M Buy
37,804
+1,281
+4% +$100K 1.09% 21
2019
Q1
$2.95M Buy
36,523
+3,175
+10% +$250K 1.08% 22
2018
Q4
$2.53M Buy
33,348
+268
+0.8% +$20.9K 1.28% 18
2018
Q3
$2.62M Sell
33,080
-83
-0.3% -$6.28K 1.05% 24
2018
Q2
$2.33M Sell
33,163
-3,612
-10% -$260K 1% 31
2018
Q1
$2.57M Sell
36,775
-3,892
-10% -$270K 1.09% 24
2017
Q4
$2.88M Buy
40,667
+877
+2% +$59.1K 1.27% 18
2017
Q3
$2.73M Buy
39,790
+1,068
+3% +$67.5K 1.34% 20
2017
Q2
$2.64M Sell
38,722
-655
-2% -$42.8K 1.52% 16
2017
Q1
$2.45M Sell
39,377
-3,417
-8% -$199K 1.37% 24
2016
Q4
$2.34M Buy
42,794
+992
+2% +$56.3K 1.09% 26
2016
Q3
$3.11M Buy
41,802
+874
+2% +$57.1K 1.31% 15
2016
Q2
$2.47M Buy
40,928
+1,127
+3% +$65.5K 1.24% 20
2016
Q1
$2.24M Buy
39,801
+9,254
+30% +$556K 1.43% 30
2015
Q4
$2.07M Buy
30,547
+766
+3% +$50.2K 1.34% 20
2015
Q3
$1.9M Sell
29,781
-1,019
-3% -$67K 2.69% 18
2015
Q2
$1.96M Buy
30,800
+1,977
+7% +$135K 1.21% 25
2015
Q1
$1.97M Sell
28,823
-27,906
-49% -$1.94M 1.31% 22
2014
Q4
$1.91M Buy
+56,729
New +$4.06M 1.46% 21

Other funds holding AZN

Pinkerton Retirement Specialists's AZN Position: Q2 2026 in Review

Pinkerton Retirement Specialists reduced its AstraZeneca (AZN) stake by 51% in Q2 2026, selling an estimated $6.59M and leaving 34,253 shares worth $6.76M. The position accounts for 0.58% of the portfolio, ranked #22.

Pinkerton Retirement Specialists first reported a position in AZN in Q4 2014 and has held it in 47 quarters since. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pinkerton Retirement Specialists held 34,253 shares of AstraZeneca worth $6.76M as of Q2 2026.
  • Pinkerton Retirement Specialists sold 35,028 AstraZeneca shares in Q2 2026, an estimated $6.59M.
  • AstraZeneca made up 0.58% of Pinkerton Retirement Specialists's portfolio in Q2 2026, its #22 holding.
  • Pinkerton Retirement Specialists first reported a position in AstraZeneca in Q4 2014 and has held it in 47 quarters since.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pinkerton Retirement Specialists's 13F filing for Q2 2026, filed 30 Jul 2026.